Compounds > tretazicar

Page last updated: 2024-08-26

tretazicar and ganciclovir

tretazicar has been researched along with ganciclovir in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (14.29)	18.2507
2000's	5 (71.43)	29.6817
2010's	1 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Bridgewater, JA; Collins, MK; Knox, RJ; Michael, NP; Minton, NP; Springer, CJ	1
Chen, MJ; Chung-Faye, GA; Kerr, DJ; Searle, PF; Young, LS	1
Brunicardi, FC; Fisher, WE; Yazawa, K	1
Dachs, GU; Hunt, MA; Patterson, AV; Singleton, DC; Syddall, S	1
Foygel, K; Paulmurugan, R; Sekar, TV; Willmann, JK	1

Reviews

3 review(s) available for tretazicar and ganciclovir

Article	Year
Gene therapy for colorectal cancer: therapeutic potential. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2001, Volume: 15, Issue:6 Topics: Adenoviridae; Antigen Presentation; Aziridines; Carcinoembryonic Antigen; Clinical Trials as Topic; Colorectal Neoplasms; Flucytosine; Ganciclovir; Genes, p53; Genetic Therapy; Humans; T-Lymphocytes, Cytotoxic	2001
Current progress in suicide gene therapy for cancer. World journal of surgery, 2002, Volume: 26, Issue:7 Topics: Animals; Antiviral Agents; Arabinonucleosides; Aziridines; Clinical Trials as Topic; Cytosine Deaminase; Escherichia coli; Flucytosine; Ganciclovir; Genetic Therapy; Genetic Vectors; Herpesvirus 3, Human; Humans; Neoplasms; Nitroreductases; Nucleoside Deaminases; Pentosyltransferases; Prodrugs; Purine Nucleosides; Simplexvirus; Thymidine Kinase; Xanthines	2002
Bystander or no bystander for gene directed enzyme prodrug therapy. Molecules (Basel, Switzerland), 2009, Nov-10, Volume: 14, Issue:11 Topics: Animals; Aziridines; Cytosine Deaminase; Flucytosine; Ganciclovir; Genetic Therapy; Humans; Nitroreductases; Prodrugs; Thymidine Kinase	2009

Other Studies

4 other study(ies) available for tretazicar and ganciclovir

Article	Year
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954. European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:13-14 Topics: 3T3 Cells; Animals; Aziridines; Drug Therapy, Combination; Escherichia coli; Ganciclovir; Gene Transfer Techniques; Genes, Bacterial; Genes, Viral; Humans; Mice; Nitroreductases; Prodrugs; Thymidine Kinase; Viral Structural Proteins	1995
Dual-therapeutic reporter genes fusion for enhanced cancer gene therapy and imaging. Gene therapy, 2013, Volume: 20, Issue:5 Topics: Animals; Apoptosis; Aziridines; Breast Neoplasms; Cell Line, Tumor; Escherichia coli; Escherichia coli Proteins; Ganciclovir; Genes, Reporter; Genetic Therapy; Humans; Mice; Nitroreductases; Prodrugs; Recombinant Fusion Proteins; Simplexvirus; Thymidine Kinase; Transplantation, Heterologous	2013